These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 15666780

  • 1. Molecular mechanisms of cell cycle control in the mouse Y1 adrenal cell line.
    Costa ET, Forti FL, Rocha KM, Moraes MS, Armelin HA.
    Endocr Res; 2004 Nov; 30(4):503-9. PubMed ID: 15666780
    [Abstract] [Full Text] [Related]

  • 2. Deconstructing the molecular mechanisms of cell cycle control in a mouse adrenocortical cell line: roles of ACTH.
    Rocha KM, Forti FL, Lepique AP, Armelin HA.
    Microsc Res Tech; 2003 Jun 15; 61(3):268-74. PubMed ID: 12768542
    [Abstract] [Full Text] [Related]

  • 3. c-Myc protein is stabilized by fibroblast growth factor 2 and destabilized by ACTH to control cell cycle in mouse Y1 adrenocortical cells.
    Lepique AP, Moraes MS, Rocha KM, Eichler CB, Hajj GN, Schwindt TT, Armelin HA.
    J Mol Endocrinol; 2004 Dec 15; 33(3):623-38. PubMed ID: 15591023
    [Abstract] [Full Text] [Related]

  • 4. Signal transduction in G0/G1-arrested mouse Y1 adrenocortical cells stimulated by ACTH and FGF2.
    Lepique AP, Forti FL, Moraes MS, Armelin HA.
    Endocr Res; 2000 Nov 15; 26(4):825-32. PubMed ID: 11196459
    [Abstract] [Full Text] [Related]

  • 5. ACTH promotion of p27(Kip1) induction in mouse Y1 adrenocortical tumor cells is dependent on both PKA activation and Akt/PKB inactivation.
    Forti FL, Schwindt TT, Moraes MS, Eichler CB, Armelin HA.
    Biochemistry; 2002 Aug 06; 41(31):10133-40. PubMed ID: 12146978
    [Abstract] [Full Text] [Related]

  • 6. ACTH inhibits A Ras-dependent anti-apoptotic and mitogenic pathway in mouse Y1 adrenocortical cells.
    Forti FL, Armelin HA.
    Endocr Res; 2000 Nov 06; 26(4):911-4. PubMed ID: 11196470
    [Abstract] [Full Text] [Related]

  • 7. Role of ERK/MAP kinase in mitogenic interaction between ACTH and FGF2 in mouse Y1 adrenocortical tumor cells.
    Lotfi CF, Costa ET, Schwindt TT, Armelin HA.
    Endocr Res; 2000 Nov 06; 26(4):873-7. PubMed ID: 11196465
    [Abstract] [Full Text] [Related]

  • 8. c-Ki-ras oncogene amplification and FGF2 signaling pathways in the mouse Y1 adrenocortical cell line.
    Forti FL, Costa ET, Rocha KM, Moraes MS, Armelin HA.
    An Acad Bras Cienc; 2006 Jun 06; 78(2):231-9. PubMed ID: 16710563
    [Abstract] [Full Text] [Related]

  • 9. Differences between the growth regulatory pathways in primary rat adrenal cells and mouse tumor cell line.
    Mattos GE, Lotfi CF.
    Mol Cell Endocrinol; 2005 Dec 21; 245(1-2):31-42. PubMed ID: 16289304
    [Abstract] [Full Text] [Related]

  • 10. Unmasking a growth-promoting effect of the adrenocorticotropic hormone in Y1 mouse adrenocortical tumor cells.
    Lotfi CF, Todorovic Z, Armelin HA, Schimmer BP.
    J Biol Chem; 1997 Nov 21; 272(47):29886-91. PubMed ID: 9368063
    [Abstract] [Full Text] [Related]

  • 11. Arginine vasopressin controls p27(Kip1) protein expression by PKC activation and irreversibly inhibits the proliferation of K-Ras-dependent mouse Y1 adrenocortical malignant cells.
    Forti FL, Armelin HA.
    Biochim Biophys Acta; 2011 Aug 21; 1813(8):1438-45. PubMed ID: 21571010
    [Abstract] [Full Text] [Related]

  • 12. Arginine vasopressin inhibition of cyclin D1 gene expression blocks the cell cycle and cell proliferation in the mouse Y1 adrenocortical tumor cell line.
    Schwindt TT, Forti FL, Juliano MA, Juliano L, Armelin HA.
    Biochemistry; 2003 Feb 25; 42(7):2116-21. PubMed ID: 12590600
    [Abstract] [Full Text] [Related]

  • 13. cfos and cjun antisense oligonucleotides block mitogenesis triggered by fibroblast growth factor-2 and ACTH in mouse Y1 adrenocortical cells.
    Lotfi CF, Armelin HA.
    J Endocrinol; 2001 Mar 25; 168(3):381-9. PubMed ID: 11241169
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Control of the adrenocortical cell cycle: interaction between FGF2 and ACTH.
    Armelin HA, Lotfi CF.
    Braz J Med Biol Res; 1999 Jul 25; 32(7):841-3. PubMed ID: 10454742
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fibroblast growth factor 2 restrains Ras-driven proliferation of malignant cells by triggering RhoA-mediated senescence.
    Costa ET, Forti FL, Matos TG, Dermargos A, Nakano F, Salotti J, Rocha KM, Asprino PF, Yoshihara CK, Koga MM, Armelin HA.
    Cancer Res; 2008 Aug 01; 68(15):6215-23. PubMed ID: 18676845
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.